Calendar

Loading Events

Past Events › General

Events Search and Views Navigation

Event Views Navigation

March 2019

Hormonal Contraception and HIV Risk: Understanding the ECHO Trial

March 11, 2019 @ 9:00 am - 1:00 pm UTC-5
United Nations Foundation, 1750 Pennsylvania Ave.
Washington, DC 20006 United States
+ Google Map

A Family Planning Stakeholders Meeting Monday, March 11, 2019 9:00 am – 1:00 pm United Nations Foundation 1750 Pennsylvania Ave., 12th Floor Washington, DC 20006 The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of…

Find out more »

April 2019

Webinar: Hormonal Contraception and HIV Risk: Understanding the ECHO Trial

April 2, 2019 @ 9:00 am - 10:00 am UTC-4

Join FP2020 on April 2 to hear more about the ECHO Study. The webinar will feature: Beth Schlachter, Executive Director, FP2020 Dr. Jared Baeten, Vice Chair, Department of Global Health, University of Washington, ECHO Consortium Dr. Nelly Mugo, Research Associate Professor, Global Health, University of Washington, ECHO Management Committee Tamar Abrams, Communications Director, FP2020

Find out more »

Preparing Family Planning and HIV Advocates for ECHO Results

April 16, 2019 @ 9:00 am - 4:30 pm UTC-4
United Nations Foundation, 1750 Pennsylvania Ave.
Washington, DC 20006 United States
+ Google Map

With a special discussion on ECHO and its potential effect on youth programs Co-hosted by FP2020, AVAC, and Jhpiego/The Advocacy Collaborative United Nations Foundation 1750 Pennsylvania Avenue, NW Washington, D.C. 20006 9:00AM to 4:30PM Strategize on how HIV and FP advocacy partners can better align to prepare effective responses before and after the release of ECHO results. Meeting Objectives: Discuss preliminary mapping of current partner efforts to identify key gaps and opportunities for collaborative engagement/support Agree on concrete ways in…

Find out more »

Introduction to Planning for Outcomes (P4O) Model Webinar

April 18, 2019 @ 9:00 am - 10:00 am UTC-4

Some observational studies have raised concerns about a possible link between the use of progestogen-only injectable contraceptives, particularly depot medroxyprogesterone acetate (DMPA), and the risk of HIV acquisition. The ongoing Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial is comparing DMPA, levonorgestrel implants, and copper intrauterine device (IUD) use on risk of HIV acquisition among women in four African countries, with results expected in 2019. Depending on the evidence obtained from the ECHO trial, injectable use could be reduced…

Find out more »

Preparing for the ECHO Trial Results: WHO Perspectives

April 25, 2019 @ 7:00 am - 8:00 am UTC-4

Past observational studies have raised concerns about a possible link between the use of certain progesterone only contraceptives and the risk of HIV acquisition among populations with high HIV infection risk.  In 2012, the World Health Organization (WHO) first released guidance on use of hormonal contraception by women at high risk for HIV as part of the Medical Eligibility Criteria (MEC) for Contraceptive Use. As part of this guidance, WHO recommended that women who are at high risk for HIV…

Find out more »

May 2019

A Roadmap for Results: Supporting Countries to Plan for the ECHO Trial Results

May 7, 2019 @ 7:00 am - 8:00 am UTC-4

May 7, 7:00 am - 8:00 am EDT The global health community eagerly awaits results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which are expected in July. The ECHO trial is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of…

Find out more »

June 2019

Women Deliver 2019

June 3, 2019 - June 6, 2019
Vancouver, Canada Vancouver, British Columbia Canada + Google Map

The world's largest conference on the health, rights, and wellbeing of girls and women.

Find out more »

A Roadmap for Results: Understanding the ECHO Trial Findings (Webinar)

June 13, 2019 @ 11:00 am - 12:00 pm UTC-4

Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study will be released at SA AIDS in Durban, South Africa, on Thursday, June 13th. The ECHO team is committed to sharing these results globally – particularly with stakeholders in both the HIV and family planning communities. This webinar will provide background on the ECHO trial, present the results, and outline next steps. To ensure a coordinated and strategic response to the results at the country level, it is…

Find out more »

ECHO Study Results Announcement

June 13, 2019 @ 2:00 pm - 3:30 pm UTC+2
9th SA AIDS Conference, Hall 9, Inkosi Albert Luthuli ICC Complex, 45 Bram Fischer Rd
Durban, South Africa
+ Google Map

Save the date — June 13, 2019 — for this late-breaker session at the 9th SA AIDS Conference, which will include presentations on the primary analysis of data from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study. The announcement will occur at 2:00pm South Africa time (8:00am ET). This pivotal and long-awaited randomised clinical trial, conducted at 12 sites in Eswatini, Kenya, South Africa and Zambia, compared the relative risk of HIV acquisition among 7,829 women who used…

Find out more »

July 2019

10th IAS Conference on HIV Science

July 21, 2019 - July 24, 2019
Mexico City, Mexico Mexico City, Mexico + Google Map
Find out more »
+ Export Events